Publications by authors named "B Hrechko"
Background: Potential clinical efficacy of cystectomy in patients with metastatic bladder cancer (mBCa) remains poorly investigated. The clinical data suggest that there could be a benefit from the local treatment in selected patients with mBCa in terms of redeeming local symptoms, increasing quality of life (QoL), and decreasing the number of the potential adverse events of systemic therapy. The aim of our study was to test safety and efficacy of cystectomy in mBCa and its impact on patients' survival, QoL, and eligibility for systemic therapy.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to identify key factors influencing the choice of surgical treatment for patients with localized Renal-Cell Carcinoma (RCC) using clinical and nephrometry data.
- It involved a retrospective analysis of patients who underwent surgery for localized RCC between 2010 and 2017 and used multivariate predictive modeling to assess risks associated with surgical options.
- Results indicated that the risks for partial nephrectomy (PN) were linked to remaining functioning kidney tissue volumes for polar and lateral tumors, while tumor size was the main factor for medial tumors, with the predictive model showing high sensitivity (95.2%) and specificity (95.4%).
Purpose: This study aimed to estimate the difference between peripheral and central small renal lesions in terms of their oncologic potential.
Methods: Cross-sectional retrospective analysis of patients with small renal masses (T1a) who underwent surgical treatment between January 2008 and July 2019 at the affiliated hospital. Only patients with ccRCC pathology were included.
Purpose: This study analyzed oncological outcomes of patients with metastatic clear-cell renal cell carcinoma (ccRCC) treated with cytoreductive partial nephrectomy or nephrectomy.
Methods: This prospective non-randomized cohort study included 109 patients with metastatic ccRCC who underwent surgical treatment between 2011 and 2020. Patients were stratified into cytoreductive partial nephrectomy or nephrectomy groups.